APA (7th ed.) Citation

Maletzki, C., Schmidt, F., Dirks, W. G., Schmitt, M., & Linnebacher, M. (2013). Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: Frameshift peptides for treating MSI+ blood cancers. European journal of cancer, 49(11), . https://doi.org/10.1016/j.ejca.2013.02.035

Chicago Style (17th ed.) Citation

Maletzki, Claudia, Fabian Schmidt, Wilhelm G. Dirks, Michael Schmitt, and Michael Linnebacher. "Frameshift-derived Neoantigens Constitute Immunotherapeutic Targets for Patients with Microsatellite-instable Haematological Malignancies: Frameshift Peptides for Treating MSI+ Blood Cancers." European Journal of Cancer 49, no. 11 (2013). https://doi.org/10.1016/j.ejca.2013.02.035.

MLA (9th ed.) Citation

Maletzki, Claudia, et al. "Frameshift-derived Neoantigens Constitute Immunotherapeutic Targets for Patients with Microsatellite-instable Haematological Malignancies: Frameshift Peptides for Treating MSI+ Blood Cancers." European Journal of Cancer, vol. 49, no. 11, 2013, https://doi.org/10.1016/j.ejca.2013.02.035.